ATMEKSI
Launchmethocarbamol
NDAORALSUSPENSION
Approved
Jul 2025
Lifecycle
Launch
Competitive Pressure
0/100
Mechanism of Action
12.1 Mechanism of Action The mechanism of action of methocarbamol in humans has not been established but may be due to general central nervous system (CNS) depression. It has no direct action on the contractile mechanism of striated muscle, the motor end plate, or the nerve fiber. 12.3…
Pharmacologic Class:
Muscle Relaxant
Loss of Exclusivity
LOE Date
Oct 9, 2044
226 months away
Patent Expiry
Oct 9, 2044
Patent Records (1)
| Patent # | Expiry | Type | Use Code |
|---|---|---|---|
| 12390439 | Oct 9, 2044 | Product | U-4253 |